Conclusion de contrats de coentreprise entre Shangai Zuquan Investment Management Company Limited d’une part et Epygon, Kephalios et MyoPowers d’autre part.
Recent Posts
- Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026
- Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme
- 2 – Spécialiste produit Urologie / Product specialist Urology
- Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software
- Spécialiste produit Urologie / Product specialist Urology
Recent Comments